🔊CEOInterviews

Gail Boudreaux on Medicaid

From Elevance Health Inc ($ELV) Q1 2025 Earnings Call · · Castify Earnings Call

“In Medicaid, we continue to make progress on rate alignment with April adjustments coming in as expected and early discussions for the July cohort underway. These conversations reflect a shared understanding of the need to align reimbursement with the current level of acuity of our membership.”

Gail Boudreaux
President, Chief Executive Officer & Director, Elevance Health Inc
Policy Impact Medicaidrate alignmentreimbursement policy

On , Gail Boudreaux, President, Chief Executive Officer & Director at Elevance Health Inc, spoke about Medicaid during Elevance Health Inc ($ELV) Q1 2025 Earnings Call on Castify Earnings Call.

Elevance Health Inc ($ELV) Q1 2025 Earnings Call
Watch on YouTube at 6:21
Elevance Health Inc ($ELV) Q1 2025 Earnings Call
Castify Earnings Call
Watch on YouTube at 6:21
ELV - Earnings call Q1 2025.
Gail Boudreaux

About Gail Boudreaux

President, Chief Executive Officer & Director · Elevance Health Inc

Gail Boudreaux, president and CEO of Elevance Health, reported at the company's 2026 annual meeting that Elevance Health generated $197.6 billion in operating revenue in 2025, a 13% increase from the prior year, and returned $4.1 billion to shareholders through dividends and share repurchases. She said the company was advancing its "whole health" approach by integrating physical, behavioral, pharmacy, and social care and scaling the use of artificial intelligence across operations. Boudreaux also noted that a shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan political groups did not pass. During previous earnings calls in 2025, Boudreaux discussed challenges in the Medicaid and ACA markets. In the second quarter, she revised the full-year 2025 adjusted EPS guidance to approximately $30, citing elevated medical cost trends and slower-than-expected Medicaid rate alignment. She also described legal action against what she described as misuse of the independent dispute resolution process under the No Surprises Act, alleging that out-of-network providers had submitted inflated payment requests. In the third quarter, Boudreaux stated that Elevance Health was planning for at least a 125 basis point year-over-year decline in Medicaid margins and noted that if Congress allowed enhanced premium tax credits to expire, it would significantly impact 2026 membership. She emphasized that the company was prioritizing long-term performance over near-term expense leverage.

Profile compiled from Gail Boudreaux's verified public interviews and appearances. See all quotes & transcripts →

More from Gail Boudreaux Elevance Health (ELV) Full Transcript Explore All Executives